Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 10, October 2018, Pages 709-792
 
MONOGRAPHS
 
  
 KPT-9274.
First-in-class dual inhibitor of NAMPT and PAK-4, Treatment of advanced solid malignancies, Treatment of non-Hodgkin's lymphoma.
Cho, D.
Drugs Fut 2018, 43(10): 709
Summary | Full Text: PDF 
 
  
  
 Lemborexant.
Dual orexin receptor antagonist, Treatment of insomnia.
Hoyer, D., Jacobson, L.H.
Drugs Fut 2018, 43(10): 715
Summary | Full Text: PDF 
 
  
  
 Upadacitinib tartrate.
Tyrosine-protein kinase JAK1 inhibitor, Treatment of autoimmune inflammatory diseases, Treatment of rheumatoid arthritis.
Gajdosik, Z.
Drugs Fut 2018, 43(10): 731
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Torramade, E., Molas, G., Tell, M., Presa, A.
Drugs Fut 2018, 43(10): 745
Full Text: PDF 
 
  
  
 NME Digest.
Bofill, X., Cole, P., Fernandez-Forner, D., Torramade, E.
Drugs Fut 2018, 43(10): 755
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 American Diabetes Association – 78th Scientific Sessions. Orlando, Florida, USA – June 22-26, 2018.
Mason, V.L.
Drugs Fut 2018, 43(10): 771
Summary | Full Text: PDF 
 
  
  
 European Society of Cardiology (ESC) Congress 2018. Munich, Germany – August 25-29, 2018.
Puzzovio, S.
Drugs Fut 2018, 43(10): 777
Summary | Full Text: PDF 
 
  
  
 European Federation of Medicinal Chemistry – XXV International Symposium on Medicinal Chemistry. Ljubljana, Slovenia – September 2-6, 2018.
Pares, S., Navarro, E.
Drugs Fut 2018, 43(10): 783
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences